Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: Neurobehav HIV Med. 2013 Jun 19;5:11–22. doi: 10.2147/NBHIV.S39573

Table 2.

Demographic and clinical characteristics

ε4+
(n = 77)
Mean (SD)
ε4−
(n = 182)
Mean (SD)
Age (years) 43.91 (7.72) 43.34 (7.88)
Age over 50 years (%) 23.4 21.4
Education (years)a 14.00 (2.50) 13.07 (2.55)
WRAT-III (SS) 98.62 (14.83) 96.52 (14.14)
Cognitive reservea 101.21 (13.08) 97.45 (12.26)
Sex (% male) 87.0 83.5
Ethnicity (%)
    African American 35.1 25.8
    Latino 9.1 13.2
    Caucasian 50.6 57.1
    Other 5.2 3.8
CD4+ (T cell count) 219.40 (243.93) 219.23 (243.03)
Length of infection (years)b 11.12 (5.12) 11.61 (5.54)
HAART (% prescribed) 84.4 84.6
Hepatitis C (% positive) 11.7 11.0
Substance use/abuse (%)c 27.3 25.9
Major depression (%)d 19.7 24.7

Notes:

a

P < 0.05;

b

n = 252;

c

n = 194;

d

n = 216.

Abbreviations: HAART, highly active antiretroviral therapy; SD, standard deviation; WRAT-III, Wide Range Achievement Test, 3rd edition.